Relationship and between physicochernical characteristics functional properties of chitosan

被引:69
作者
Kofuji, K [1 ]
Qian, CJ [1 ]
Nishimura, M [1 ]
Sugiyama, I [1 ]
Murata, Y [1 ]
Kawashima, S [1 ]
机构
[1] Hokuriku Univ, Fac Pharmaceut Sci, Kanagawa, Kanazawa 9201181, Japan
关键词
chitosan; gel; molecular weight; deacetylation; biodegradation; drug release;
D O I
10.1016/j.eurpolymj.2005.04.041
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
In order to select an ideal chitosan (CS) species as a material for implantation vehicle to control drug release in the body, the relationship between physicochemical characteristics (including molecular weight, degree of deacetylation, and viscosity) and functional properties (including ability to form spherical gel, control of drug release from CS gel, and biodegradation of CS) was investigated for various CS. The case of spherical gel formation in aqueous amino acid solution or aqueous solution containing metal ions was affected mainly by viscosity of the CS solution. Drug diffusion rate from the CS gel was controlled by density of the gel matrix structure, which was governed by viscosity of the CS solution prior to gelation. Biodegradation of CS tended to vary with degree of deacetylation. However, linear relationships for these trends were not observed, and the possibility that characteristics other than CS molecular weight, degree of deacetylation, and viscosity of the CS solution, such as distribution of acetamide groups in the CS molecule affect functional properties of CS, was also indicated. These observations demonstrate that CS functions are affected by various CS characteristics and that investigation of individual CS characteristics is important for the selection of the appropriate CS as a material for drug delivery vehicles. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2784 / 2791
页数:8
相关论文
共 35 条
[1]   STUDIES ON CHITOSAN .4. LYSOZYMIC HYDROLYSIS OF PARTIALLY N-ACETYLATED CHITOSANS [J].
AIBA, S .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1992, 14 (04) :225-228
[2]   Chitosan and its derivatives:: potential excipients for peroral peptide delivery systems [J].
Bernkop-Schnürch, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 194 (01) :1-13
[3]   Chitosans for gene delivery [J].
Borchard, G .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 52 (02) :145-150
[4]   CHITIN VARIABILITY WITH SPECIES AND METHOD OF PREPARATION [J].
BRINE, CJ ;
AUSTIN, PR .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1981, 69 (02) :283-286
[5]   Physicochemical characteristics and functional properties of various commercial chitin and chitosan products [J].
Cho, YI ;
No, HK ;
Meyers, SP .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1998, 46 (09) :3839-3843
[6]   Pharmaceutical applications of chitosan [J].
Dodane, V ;
Vilivalam, VD .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (06) :246-253
[7]   CONTROLLED RELEASE OF BISPHOSPHONATE FROM A BIODEGRADABLE IMPLANT - EVALUATION OF RELEASE KINETICS AND ANTICALCIFICATION EFFECT [J].
GOLOMB, G ;
LEVI, M ;
VANGELDER, JM .
JOURNAL OF APPLIED BIOMATERIALS, 1992, 3 (01) :23-28
[8]   N-ACETYLATION IN CHITOSAN AND THE RATE OF ITS ENZYMIC-HYDROLYSIS [J].
HIRANO, S ;
TSUCHIDA, H ;
NAGAO, N .
BIOMATERIALS, 1989, 10 (08) :574-576
[9]   Implantable applications of chitin and chitosan [J].
Khor, E ;
Lim, LY .
BIOMATERIALS, 2003, 24 (13) :2339-2349
[10]   Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid β peptide and interieukin-1β [J].
Kim, MS ;
Sung, MJ ;
Seo, SB ;
Yoo, SJ ;
Lim, WK ;
Kim, HM .
NEUROSCIENCE LETTERS, 2002, 321 (1-2) :105-109